PEG-Asc Vs. SPMC for Bowel Preparation in Capsule-based Procedures

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

August 30, 2025

Conditions
Bowel Preparation Solution
Interventions
DRUG

Polyethylene Glycol plus Ascorbic Acid (PEG-Asc)

Participants receive a split-dose bowel preparation with 1 L polyethylene glycol plus ascorbic acid (PEG-Asc). The first dose is administered at 20:00 the evening before the procedure (500 mL PEG-Asc solution consumed over 1 hour, followed by 500 mL clear liquids). The second identical dose is taken at 06:00 on the day of the capsule procedure.

DRUG

Sodium Picosulfate with Magnesium Citrate (SPMC)

Participants receive sodium picosulfate with magnesium citrate (SPMC) in a split-dose regimen. The first sachet is dissolved in 150 mL water and followed by 1.5-2 L of clear fluids the evening before the procedure, and the second sachet is taken with the same fluid regimen on the morning of the procedure.

Trial Locations (1)

4835-044

Unidade Local de Saúde do Alto Ave (ULSAAVE), Guimarães

All Listed Sponsors
lead

Unidade Local de Saúde do Alto Ave, EPE

OTHER

NCT07206329 - PEG-Asc Vs. SPMC for Bowel Preparation in Capsule-based Procedures | Biotech Hunter | Biotech Hunter